Robert Chisholm, Ph.D.

Deep experience with patent matters for health and life sciences industries

Robert Chisholm guides health and life sciences clients of all sizes in the prosecution of domestic and international patent-related matters. He also handles infringement and validity analyses, due diligence analyses of patent portfolios involved in mergers and acquisitions, and intellectual property (IP) agreements. Robert has patent experience with a vast array of technologies, including:

• Antibody fragments
• Peptide antibiotics
• Enzymes
• Small molecules
• Hematology analysis devices and associated diagnostic methods
• Lateral flow-based diagnostics
• Polymer recycling, fuel cells and petroleum processing

Robert dives deep into technologies when counseling clients in patent-related matters to develop a tailored patent strategy with the goal of maximizing patent protection for current and future commercialization efforts.

Prior to his legal career, Robert had more than nine years of research experience, which included working as a postdoctoral researcher at the Stowers Institute for Medical Research. In that role, he conducted biomedical research on the relationship between eukaryotic gene expression and mitosis. While a graduate student, Robert performed biochemical and biophysical research on several macromolecular complexes.

Admitted in Kansas and Missouri. Not admitted in Illinois.

• Drafting and prosecuting patent applications with an emphasis in the life science and chemical industries.
• Providing freedom-to-operate opinions and landscape analyses.
• Providing noninfringement and invalidity opinions and performing due diligence analyses.

• Performed IP due diligence on a $2 billion-plus acquisition for a medium-sized pharmaceutical client.
• Managed a patent portfolio of a medium-sized pharmaceutical company and a patent portfolio of a biomedical diagnostics company.